WASHINGTON, Dec. 19, 2023 /PRNewswire/ -- The Association of Black Cardiologists announced today the launch of its Hypertension Control Program. The program will offer 50 member clinicians the opportunity to receive American Hypertension Specialist Certification in clinical hypertension care Continue reading →

Memory researcher Fabricio Ballarini says that couples often rely on each others brains to store and recall memories. When a partner dies or leaves, a part of the other halfs memory seems to disappear as well. Continue reading →

MURRAY, Utah (ABC4 Utah) Pulmonary Hypertension, or PH, is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. PH is a progressive rare disease is defined by high blood pressure in the lungs and can cause right-heart failure and even death. PH is a contributing factor to more than 18,000 adult deaths each year in the United States Continue reading →

WAKEFIELD, Mass., Dec. 19, 2023 /PRNewswire/ -- Ablative Solutions, Inc., today announced that the TARGET BP I Pivotal Trial evaluating alcohol-mediated renal denervation with the Peregrine SystemKit met its primary endpoint, showing a statistically significant difference in 24-hour Ambulatory Blood Pressure between treatment and sham procedure at 3 months. The TARGET BP I trial evaluated the safety and efficacy of the Peregrine System Kit to treat patients with uncontrolled hypertension while taking anti-hypertensive medications Continue reading →

Warning that extreme cold weather heightens the risk of brain stroke and haemorrhage in individuals with hypertension and cardiovascular risks, health experts have advised such people to take preventive steps, including regular health check-ups and maintaining optimal blood pressure levels. Among various health impacts associated with colder temperatures, studies have shed light on a concerning correlation between cold weather and an elevated risk of brain haemorrhage, presenting a critical nexus between temperature and health outcomes. A series of pivotal studies published in esteemed medical journals, including ScienceDirect, American Heart Association Journals, and PubMed, have unearthed an alarming connection: cold weather significantly amplifies the vulnerability to brain haemorrhage, impacting individuals with hypertension and normotensive individuals alike, said Dr Manish Vaish, Senior Director, Neurosurgery, at Max Super Speciality Hospital, Delhi. Continue reading →

Topline data from confirmatory Launch-HTN trial expected in 2H 2025 Topline data from ongoing Advance-HTN pivotal trial expected in 2H 2024 RADNOR, Pa., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases driven by abnormally elevated aldosterone, today announced that the first subject has been dosed in the Launch-HTN (NCT06153693) pivotal trial to evaluate the safety and efficacy of lorundrostat for the treatment of uncontrolled hypertension (uHTN) or resistant hypertension (rHTN), when used as an add-on therapy to prescribed background treatment. Continue reading →